Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | SLB | ECL |
|---|---|---|
| Price | $51.80 | $274.79 |
| Change today | ▼ 0.14% | ▼ 0.70% |
| Market cap | $76.87B | $77.03B |
| Return, 3 months | +11.7% | -0.5% |
| Return, year to date | +37.2% | +5.2% |
| Return, 1 year | +53.3% | +3.8% |
| P/E (TTM) | 25.3 | 36.9 |
| P/B | 2.9 | 7.7 |
| P/E percentile vs own 5y | 79th | 26th |
| Dividend yield | 2.24% | 1.03% |
| Revenue growth (YoY, latest qtr) | +5.0% | +9.7% |
| Net profit growth (YoY) | -22.2% | +1.9% |
| Gross margin | 16.5% | 44.1% |
| Operating margin | 13.7% | 18.1% |
| Net margin | 8.5% | 12.6% |
| Return on equity | 13.4% | 21.8% |
| Analyst target vs. price | +23.4% | +17.8% |
| Analyst buy share | 100% | 94% |
| RSI (14) | 44 | 48 |
| 30-day volatility | 35.8% | 18.1% |
| Max drawdown, 1 year | -22.3% | -20.1% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.